Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Assets: 2019-2023

Historic Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $375.6 million.

  • ADC Therapeutics' Current Assets fell 14.27% to $375.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $375.6 million, marking a year-over-year decrease of 14.27%. This contributed to the annual value of $435.0 million for FY2022, which is 17.18% down from last year.
  • As of Q3 2023, ADC Therapeutics' Current Assets stood at $375.6 million, which was down 9.01% from $412.8 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Current Assets ranged from a high of $568.4 million in Q3 2021 and a low of $359,125 during Q2 2020.
  • Moreover, its 3-year median value for Current Assets was $424.4 million (2022), whereas its average is $439.5 million.
  • Per our database at Business Quant, ADC Therapeutics' Current Assets soared by 112,140.65% in 2021 and then decreased by 22.93% in 2022.
  • Over the past 5 years, ADC Therapeutics' Current Assets (Quarterly) stood at $122.6 million in 2019, then reached $506,419 in 2020, then soared by 112,140.65% to $525.2 million in 2021, then fell by 17.18% to $435.0 million in 2022, then fell by 14.27% to $375.6 million in 2023.
  • Its Current Assets was $375.6 million in Q3 2023, compared to $412.8 million in Q2 2023 and $380.0 million in Q1 2023.